ICYMI: Political Courage Needed to Deliver on Drug Prices

Political Courage Needed to Deliver on Drug Prices By Lauren Aronson Real Clear Health November 22, 2019 The egregious pricing behavior of pharmaceutical giants has sparked a crisis of prescription

11-25-2019 Read More

CSRXP SENATE BATTLEGROUND POLL: VOTERS BACK GRASSLEY-WYDEN, DEMAND ACTION TO HOLD BIG PHARMA ACCOUNTABLE

Survey Finds Overwhelming Majorities of Swing State Voters Blame Drug Makers for Rising Prices and Want Congress to Pass Bipartisan Reforms Before Year End For Immediate Release Contact: Jon Conradi

11-22-2019 Read More

ICYMI: GALLUP FINDS NEARLY 58 MILLION AMERICANS UNABLE TO AFFORD THEIR PRESCRIPTION DRUGS, UP FOUR PERCENT FROM JANUARY

Nine in Ten Surveyed Adults Believe Rx Prices “Much Higher” Or “Somewhat Higher” Than Reasonable A new Gallup survey demonstrates the rising toll of out-of-control prescription drug prices

11-13-2019 Read More

SECOND OPINION: BIG PHARMA SQUARELY TO BLAME FOR RISING MEDICARE PREMIUMS

Drug Makers Cry ‘False Narrative’ Over Latest Repot Highlighting Toll of the Industry’s Egregious Pricing Practices Last week, the Centers for Medicare & Medicaid Services (CMS) released a

11-12-2019 Read More

Q3 Earnings: Big Pharma Keeps The Good Times Rolling While Hiking Prices

Q3 Earnings: Big Pharma Keeps The Good Times Rolling While Hiking Prices Top Brand Name Drug Makers Best Earnings Forecasts While Evading Accountability And that’s a wrap! Three weeks of earnings

11-7-2019 Read More

AMERICANS AGREE: CONGRESS MUST ACT TO HOLD BIG PHARMA ACCOUNTABLE AND LOWER DRUG PRICES

Solutions to Reform Medicare Part D, Increase Competition and Boost Transparency Have Broad Bipartisan Support, Should Be Swiftly Passed THE CRISIS OF RISING PRESCRIPTION DRUG PRICES The

11-4-2019 Read More

Big Pharma Earnings Watch: Abbvie

Brand Name Drug Giant Completes Sweep of Big Pharma Companies Who Beat Expectations After Hiking Prices Earnings reports for the third quarter of the year provide the latest evidence that Big Pharma

11-1-2019 Read More

BIG PHARMA EARNINGS WATCH: BRISTOL-MYERS SQUIBB AND SANOFI

Good Times Rolling for Brand Name Drug Makers, Two More Top Earnings Forecasts After Increasing Prices Two more brand name giants – Bristol-Myers Squibb and Sanofi – topped earnings expectations

10-31-2019 Read More

Big Pharma Earnings Watch: Glaxosmithkline and Amgen

Big Pharma’s Earnings Keep Rising Off of Price Hikes To no one’s surprise, two more brand name drug manufacturers, GlaxoSmithKline (GSK) and Amgen both topped earnings expectations for the third

10-30-2019 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.